Cash Flow from Operating Activities: A company's cash flows from operations.
Protagonist Therapeutics, Inc. (PTGX) had Cash Flow from Operating Activities of $170.11M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$213.47M |
|
$162.85M |
|
-- |
|
$213.47M |
|
$54.71M |
|
$158.77M |
|
$6.35M |
|
$165.11M |
|
$165.11M |
|
$162.85M |
|
$162.85M |
|
$162.85M |
|
$162.85M |
|
$158.77M |
|
$157.68M |
|
65.94M |
|
71.01M |
|
$2.47 |
|
$2.29 |
|
| Balance Sheet Financials | |
$807.15M |
|
$3.46M |
|
$78.40M |
|
$885.54M |
|
$37.18M |
|
-- |
|
$6.82M |
|
$44.00M |
|
$841.54M |
|
$841.54M |
|
$841.54M |
|
64.67M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$170.11M |
$88.46M |
|
$33.12M |
|
$128.68M |
|
$420.37M |
|
$291.69M |
|
$28.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
21.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
74.37% |
|
74.37% |
|
-- |
|
77.35% |
|
76.28% |
|
$169.73M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
-- |
|
15.91 |
|
5.66 |
|
19.35% |
|
19.35% |
|
18.39% |
|
19.35% |
|
$13.01 |
|
$2.39 |
|
$2.40 |
|